APVO Earnings Aptevo Therapeutics Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -6.41 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -87.27 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -11.42 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -30.84 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -1581.81 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -31460.23 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -3709.76 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -4458.98 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -368.21 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -2316.83 | 2025-02-14 | 10-K |
| Q3 2024 | 2023-09-30 | -56.22 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -31.67 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | 17.38 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | 1.57 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | 2.52 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | 4.08 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.55 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -6.07 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -4.80 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -3.39 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.